European Patent Application No. 04756741.7 (Our Ref: WSK-PU-001-EP1) Examination of the application has been requested. Annuity Fees due 31st July 2010.
European Patent Application No. 08713370.8, entitled “Metastasis specific splice variants of Mena and uses thereof in diagnosis, prognosis and treatment of tumors”, inventors: Xxxx Xxxxxxxxx, Xxxxxxx Xxxxxxx, Xxxxx Xxxxxxx, and Xxxxx Xxxxxxx; assigned to Einstein, IFO and MIT (96700/1534); and
European Patent Application No. 00000000.5;Japanese Patent Application No. 2010.517480 (issued as Japanese Patent No. 0000000);Korean Patent Application No. 00-0000-0000000 (issued as Korean Patent No. 101646978);US Non-provisional Patent Application No. 12/178,116 (issued as US Patent No. 8,706,422);Hong Kong Patent Application No. 10110584.9;European Divisional 1 Patent Application No. 12180122.9;European Divisional 2 Patent Application No. 92180129.4 (issued as European Patent No. 2557518 and validated in France, Germany and Great Britain);European Divisional 3 Patent Application No. 12180133.6;European Divisional 4 Patent Application No. 12180138.5;Australian Divisional 4 Patent Application No. 0000000000 (issued as Australian Patent No. 0000000000);Australian Divisional 3 Patent Application No. 2013202141 (issued as Australian Patent No. 2013202141);Australian Divisional 2 Patent Application No. 2013202160 (issued as Australian Patent No. 2013202160); Australian Divisional 1 Patent Application No. 0000000000 (issued as Australian Patent No. 0000000000);Hong Kong Divisional 1 Patent Application No. 13109377.9;Hang Kong Divisional 2 Patent Application No. 13109380.4;Hong Kong Divisional 3 Patent Application No. 13109379.7;Hong Kong Divisional 4 Patent Application No. 13109427.9;US Divisional 1 Patent Application No. 14/030,904;Japanese Divisional 1 Patent Application No. 2013-267526;Chinese Divisional 1 Patent Application No. 201410052009.7;Chinese Divisional 2 Patent Application No. 201410051659.X;Chinese Divisional 3 Patent Application No. 201410051950.7;Macau Patent Application No. J/001408 (issued as Macau Patent No. J/001408);Hong Kong Patent Application No. 14112444.1;Australian Divisional 5 Patent Application No. 2015271883Japanese Divisional 2 Patent Application No. 2016-131552; andKorean Divisional 1 Patent Application No. 10-2016-7021211Korean Divisional 2 Patent Application No. 10-2016-7021212Korean Divisional 3 Patent Application No. 10-2016-7021213Korean Divisional 4 Patent Application No. 00-0000-0000000 2.01/MED/070 Gastric Disease Detection System US Patent Application No. 10/057,579 (issued as US Patent No. 6,753,137) European Patent No. EP1356124B1
European Patent Application No. 95907670.4 - Filed on 15 August 1996 - Granted on 5 January 2000 - Patent No. 0749342 - Registered in the following countries as national patents:
European Patent Application No. 95916338.7 Designating: Austria, Belgium, Switzerland, Germany, Denmark, Spain, France, United Kingdom, Greece, Ireland, Italy, Luxembourg, Monaco, Netherlands, Portugal, Sweden Japan Patent Application No. 8-531673 Mexico Patent Application No. 97-8000 Singapore Patent Application No. 9705696-4
European Patent Application No. 96919139.4, "Dinucleotides Useful For The Treatment of Lung Disease", X.X. Xxxxxx, III, X.X. Xxxxxxx, Xx., X.X.
European Patent Application No. 96909151.1 (8) Indian Patent Application No. 589/Cal/96 (9) Indonesian Patent Application No. P960882 (10) Israeli Patent No. 117808 (11) Japanese Patent Application No. 529960/96 (12) Korean Patent Application No. 97-706854 (13) Malaysian Patent Application No. PI96001293 (14) Philippines Patent Application No. 52778 (15) South African Patent No. 96/2755 (16) Taiwanese Patent No. 129162 (17) Thailand Patent Application No. 030767 [**]
European Patent Application No. 97910380.1
European Patent Application No. 17793304.1 titled “A Delta-Opioid Receptor Targeted Agent For Molecular Imaging And Immunotherapy Of Lung Cancer” filed December 4, 2018 (Moffitt ID No. 16MA029PRWOEP) ● Israeli Patent Application No. 262743 titled “A Delta-Opioid Receptor Targeted Agent For Molecular Imaging And Immunotherapy Of Lung Cancer” filed November 4, 2018 (Moffitt ID No. 16MA029PRWOIL) ● Japanese Patent Application No. 2018-558190 titled “A Delta-Opioid Receptor Targeted Agent For Molecular Imaging And Immunotherapy Of Lung Cancer” filed November 5, 2018 (Moffitt ID No. 16MA029PRWOJP)
European Patent Application No. 01303901.1 (11) Indian Patent Application No. IN/PCT/2000/00181 (12) Japanese Patent Application No. 586367/00 (13) Korean Patent Application No. 00-0000-0000000 (14) Mexican Patent Application No. 007720 (15) Thailand Patent Application No. 054263 (16) Taiwanese Patent Application No. 88121127 ** Certain information in these exhibits has been omitted and will be filed separately with the Securities and Exchange Commission pursuant to a confidential treatment request. `932 PATENT RIGHTS
